We are live on
!
Find out more
Rafferty Asset Management Portfolio holdings
AUM
$24.6B
1-Year Est. Return
47.06%
This Fund
S&P 500
This Quarter
Est. Return
+8.79%
1 Year Est. Return
+47.06%
3 Year Est. Return
+108.18%
5 Year Est. Return
+135.84%
10 Year Est. Return
+427.13%
AUM
$17.7B
AUM Growth
+$2.98B
(+20%)
Cap. Flow
+$1.81B
Cap. Flow
% of AUM
10.19%
Top 10 Holdings %
Top 10 Hldgs %
35.18%
Holding
1,173
New
33
Increased
727
Reduced
328
Closed
84
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$505M |
| 2 |
Intel
INTC
|
+$122M |
| 3 |
Apple
AAPL
|
+$122M |
| 4 |
Microsoft
MSFT
|
+$98.1M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$97.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$90.1M |
| 2 |
VanEck Gold Miners ETF
GDX
|
+$37.3M |
| 3 |
iShares MSCI Brazil ETF
EWZ
|
+$32.8M |
| 4 |
State Street SPDR Bloomberg High Yield Bond ETF
JNK
|
+$15.9M |
| 5 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$15.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 45.79% |
| 2 | Financials | 10.21% |
| 3 | Healthcare | 7.68% |
| 4 | Consumer Discretionary | 4.29% |
| 5 | Energy | 4.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Allstate
ALL
$68.3B
| $9.2M | 0.05% |
84,335
-4,311
| -5% | -$489K |
|
227
Warner Bros
WBD
$63.9B
| $9.19M | 0.05% |
733,198
+203,263
| +38% | +$2.64M |
|
228
Caterpillar
CAT
$373B
| $9.16M | 0.05% |
37,245
+3,280
| +10% | +$731K |
|
229
Halliburton
HAL
$26.4B
| $8.99M | 0.05% |
272,543
-23,588
| -8% | -$745K |
|
|
BPMC
230
DELISTED
Blueprint Medicines
BPMC
| $8.97M | 0.05% |
141,997
-19,893
| -12% | -$1.08M |
|
231
Arch Capital
ACGL
$34.5B
| $8.94M | 0.05% |
119,459
-5,219
| -4% | -$377K |
|
232
BridgeBio Pharma
BBIO
$16.1B
| $8.93M | 0.05% |
519,246
+177,966
| +52% | +$2.68M |
|
|
EXAS
233
DELISTED
Exact Sciences
EXAS
| $8.88M | 0.05% |
94,600
-15,162
| -14% | -$1.18M |
|
234
Halozyme
HALO
$9.88B
| $8.82M | 0.05% |
244,545
+81,102
| +50% | +$2.77M |
|
235
Kraft Heinz
KHC
$31.3B
| $8.75M | 0.05% |
246,386
+59,763
| +32% | +$2.3M |
|
236
Lucid Motors
LCID
$3.17B
| $8.74M | 0.05% |
126,909
+56,326
| +80% | +$4.02M |
|
237
Keurig Dr Pepper
KDP
$43B
| $8.7M | 0.05% |
278,255
+77,398
| +39% | +$2.54M |
|
238
Revolution Medicines
RVMD
$40.9B
| $8.69M | 0.05% |
324,943
-2,643
| -0.8% | -$64.8K |
|
239
GE Aerospace
GE
$368B
| $8.64M | 0.05% |
98,513
+9,393
| +11% | +$761K |
|
|
HZNP
240
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $8.62M | 0.05% |
83,785
+21,919
| +35% | +$2.31M |
|
241
Keysight
KEYS
$53.4B
| $8.62M | 0.05% |
51,458
+12,883
| +33% | +$2M |
|
242
Global Payments
GPN
$23.8B
| $8.58M | 0.05% |
87,087
-1,582
| -2% | -$163K |
|
243
CVS Health
CVS
$134B
| $8.58M | 0.05% |
124,057
+9,159
| +8% | +$652K |
|
|
ISEE
244
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $8.57M | 0.05% |
217,928
-97,540
| -31% | -$3.44M |
|
245
Zions Bancorporation
ZION
$10.1B
| $8.52M | 0.05% |
317,377
+68,348
| +27% | +$1.9M |
|
246
Intellia Therapeutics
NTLA
$1.55B
| $8.5M | 0.05% |
208,368
-3,020
| -1% | -$122K |
|
247
T. Rowe Price
TROW
$25.6B
| $8.48M | 0.05% |
75,658
-4,316
| -5% | -$473K |
|
248
Twist Bioscience
TWST
$5.69B
| $8.46M | 0.05% |
413,671
-17,397
| -4% | -$261K |
|
249
TransDigm Group
TDG
$69.9B
| $8.44M | 0.05% |
9,442
-1,125
| -11% | -$890K |
|
|
APLS
250
DELISTED
Apellis Pharmaceuticals
APLS
| $8.41M | 0.05% |
92,268
-17,130
| -16% | -$1.48M |
|
Similar funds
CS
AF
SC
JG
Rafferty Asset Management's Q2 2023 Portfolio in Review
As of Q2 2023, Rafferty Asset Management held 1,173 positions worth $17.7B, up 20% from $14.8B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Rafferty Asset Management deployed $1.81B of net new capital in Q2 2023, opening 33 new positions and adding to 727 existing holdings. Its largest new stake was Biomea Fusion: 136,903 shares worth $3.01M.
By sector, the portfolio is most concentrated in Technology at 46% of assets, up from 42% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was NVIDIA, an estimated $90.1M trimmed.
- Rafferty Asset Management's largest Q2 2023 buy was Biomea Fusion: 136,903 shares worth $3.01M.
- Rafferty Asset Management added most to iShares 20+ Year Treasury Bond ETF in Q2 2023, an estimated $505M increase.
- Rafferty Asset Management's biggest Q2 2023 reduction was NVIDIA, cutting an estimated $90.1M.
- Rafferty Asset Management fully exited Prometheus Biosciences, Inc. Common Stock in Q2 2023, selling an estimated $6.38M.
- Rafferty Asset Management's ten largest holdings make up 35% of its $17.7B portfolio in Q2 2023.
- Rafferty Asset Management opened 33 new positions and closed 84 in Q2 2023.
- Rafferty Asset Management's portfolio value rose 20% quarter-over-quarter to $17.7B.
Based on Rafferty Asset Management's 13F filing for Q2 2023, filed 11 Aug 2023.